MedicaSafe, Inc.   Report issue

For profit
Founded: New York NY United States (2007)
Status: No NME R&D (2007)

Organization Overview

First Clinical Trial
2018
NCT03586466
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

MedicaSafe, Inc.

Active Ingredients

Drugs in Other Trials (2)

buprenorphine (1 trial)

naloxone (narcan) (1 trial)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 1
  • # of Trial APIs: 2